drugset / Trial / NCT02980133
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is to evaluate the safety and efficacy of fluticasone propionate and fluticasone propionate salmeterol in pediatric participants with a documented history of persistent asthma.
Timeline
- Start
- 2016-12-28
- Primary completion
- 2019-04-07
- Completion
- 2019-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 25 ug | Inhaled |
| Subject | Fluticasone propionate | Other / unclassified | 50 ug | Inhaled |
| Subject | Salmeterol | Other / unclassified | 12.5 ug | Inhaled |